Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Business

A flagging U.S. industry looks for new life in a Philadelphia shipyard

by admin July 19, 2025
July 19, 2025
A flagging U.S. industry looks for new life in a Philadelphia shipyard

The U.S. shipbuilding industry is looking for help. A South Korean company is answering the call.

Hanwha Philly Shipyard CEO David Kim, nodding to the gargantuan vessels under construction just off the Delaware River, on Wednesday offered the kind of vision that has brought some optimism back to the U.S. shipbuilding community.

“You take that level of experience, the technology that we have, the know-how, the process expertise, and so clearly, we believe we have a lot to bring to the Philly Shipyard, as well as to the U.S. maritime industrial base, in terms of modernization capacity,” he said on a walkthrough of the shipyard.

Hanwha Philly Shipyard CEO David Kim.Obtained by NBC News

Hanwha Group bought the Philly Shipyard in December for $100 million and plans to invest multiple times that amount in the yard, training over a thousand new workers and bringing in new high-tech equipment. The company hopes to build naval ships and become the first U.S. builder of specialized liquefied natural gas tankers.

Shipbuilding in the United States has been all but dormant. China, South Korea, Japan and Europe all produce far more ships than the United States, with the few shipyards still operating in the country concentrating on military ships.

Revitalizing shipbuilding has been one of the areas President Donald Trump has pointed to as part of a broader effort to bring manufacturing back to the United States — a move some see as shortsighted considering the costs associated with building the kind of gigantic modern ships that remain a core part of how goods and commodities move around the planet.

This post appeared first on NBC NEWS

previous post
PETA applauds GOP lawmakers’ demand to halt NIH funding for ‘cruel’ overseas animal testing
next post
Top 5 Canadian Mining Stocks This Week: Altima is Energetic with 98 Percent Gain

Related Posts

Amazon extends Prime Day discounts to 4 days...

July 10, 2025

Temu halts shipping direct from China as de...

May 5, 2025

Disney tops quarterly profit estimates, but starts to...

February 6, 2025

23andMe to delist from Nasdaq, deregister with SEC

May 29, 2025

Dollar General CEO warns consumers are cash-strapped and...

March 15, 2025

Goldman Sachs rolls out an AI assistant for...

January 23, 2025

Oil prices rise more than 1% as Israel...

June 21, 2025

How America’s chief consumer-protection agency came into the...

February 14, 2025

DOGE plans to wind down consumer protection agency...

March 4, 2025

Businesses are cautiously spending on corporate travel as...

July 24, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 4

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved